Skip to main content

Table 2 Clinical signs of patients at inclusion

From: Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

 

DP (n, %)

AL (n, %)

Total n (%)

Fever

197 (100%)

187 (100%)

384 (100)

Headache

167 (84.8%)

153 (81.8%)

320 (83.3)

Asthenia

153 (81.8%)

106 (56.7%)

223 (58.1)

Anorexia

103 (52.3%)

95 (50.8%)

198 (51.6)

Shiver

93 (47.2%)

80 (42.8%)

173 (45.1)

Joint pain

77 (39.1%)

75 (40.1%)

152 (39.6)

Abdominal pain

35 (17.8%)

43 (23%)

78 (20.3)

Insomnia

18 (9.1%)

23 (12.3%)

41 (10.7)

Dizziness

18 (9.1%)

13 (6.9%)

31 (8.1)